Showing results (111-120 of 899) with videos related to
Sort By:
Pageof 90
Current Opinion in Allergy and Clinical Immunology|July 25, 2024
Evidence-based data support strategies for the prevention of Hymenoptera venom anaphylaxisAudrey Kamga, Jean Luc Bourrain, Pascal Demoly, et al.Expert Review of Clinical Immunology|September 2, 2015
Current controversies and challenges in allergic rhinitis managementDavid Price, Pete Smith, Peter Hellings, et al.La Revue Du Praticien|October 19, 2019
[Insurability and history of cancer]Philippe-Jean Bousquet, Lionel LafayEcology and Evolution|June 16, 2017
Asymmetry matters: A genomic assessment of directional biases in gene flow between hybridizing sprucesGuillaume de Lafontaine, Jean BousquetThe Journal of Allergy and Clinical Immunology. in Practice|April 19, 2024
Rhinitis Phenotypes Based on MultimorbiditiesÁlvaro A Cruz, Jean BousquetLa Revue Du Praticien|February 8, 2024
[After cancer: after-eff ects, return to work and the right to forget]Jérôme Foucaud, Philippe-Jean BousquetThe World Allergy Organization Journal|November 16, 2013
Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the GuidelinesJean Bousquet, William W BusseExpert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.The Journal of Allergy and Clinical Immunology|October 22, 2013
An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studiesMoises A Calderon, Thomas B Casale, Harold S Nelson, et al.Respiratory Medicine|June 16, 2014
The clinical relevance of dry powder inhaler performance for drug deliveryPascal Demoly, Paul Hagedoorn, Anne H de Boer, et al.Pageof 90